Thomas J. Appio

2019

In 2019, Thomas J. Appio earned a total compensation of $4M as President Co, Head Bausch + Lomb/International at Valeant Pharmaceuticals International, a 10% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$892,800
Option Awards$525,050
Salary$768,942
Stock Awards$1,343,982
Other$427,227
Total$3,958,001

Appio received $1.3M in stock awards, accounting for 34% of the total pay in 2019.

Appio also received $892.8K in non-equity incentive plan, $525.1K in option awards, $768.9K in salary and $427.2K in other compensation.

Rankings

In 2019, Thomas J. Appio's compensation ranked 3,025th out of 13,971 executives tracked by ExecPay. In other words, Appio earned more than 78.3% of executives.

ClassificationRankingPercentile
All
3,025
out of 13,971
78th
Division
Manufacturing
1,095
out of 5,692
81st
Major group
Chemicals And Allied Products
364
out of 2,189
83rd
Industry group
Drugs
298
out of 1,875
84th
Industry
Pharmaceutical Preparations
219
out of 1,387
84th
Source: SEC filing on May 2, 2022.

Appio's colleagues

We found three more compensation records of executives who worked with Thomas J. Appio at Valeant Pharmaceuticals International in 2019.

2019

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

2019

Paul Herendeen

Valeant Pharmaceuticals International

Chief Financial Officer

2019

Christina Ackermann

Valeant Pharmaceuticals International

General Counsel

News

You may also like